Baqsimi™ (glucagon) nasal powder

3mg

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

BAQSIMI™ (glucagon) nasal powder: Oral Administration and Ingestion

Oral administration and ingestion of Baqsimi (glucagon nasal powder) has not been studied in people with diabetes.

Detailed Information

Oral administration and ingestion of Baqsimi has not been studied in people with diabetes. As such, we have no information on the oral or buccal absorption of Baqsimi.

Glucagon is a single-chain polypeptide.1,2

Glucagon for injection is not active when administered and ingested orally because it is a polypeptide that is destroyed in the gastrointestinal tract before it can be absorbed.2 

Enclosed Prescribing Information

BAQSIMI™ (glucagon) nasal powder, for intranasal use, Lilly

GLUCAGON FOR INJECTION, Lilly

References

1. Baqsimi [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.

2. Glucagon for Injection [package insert]. Indianapolis, IN: Eli Lilly and Company; 2018.

Glossary

Baqsimi = Baqsimi™ (glucagon) nasal powder

Date of Last Review: August 23, 2019

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 8am - 7pm ET

Or you can

Ask us a question Chat with us

Submit a Request

Visit Us @LillyMedical